Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 OSE Immunotherapeutics Receives Grant to Advance COVID-19 Vax | Contract Pharma

What are you searching for?

Sign in
Breaking News

OSE Immunotherapeutics Receives Grant to Advance COVID-19 Vax

OSE’s research program aims to develop a prophylactic vaccine focused on memory T cells and based on a multiepitope-peptide approach.

By: Contract Pharma

Contract Pharma Staff

OSE Immunotherapeutics will receive a grant of up to €200,000 from Nantes Metropole, a community dedicated to the development of a prophylactic vaccine against the pandemic virus SARS-CoV-2. This funding was awarded as part of the Metropolitan Fund to Support Health Innovations Linked to the COVID-19 Health Crisis.

OSE is working on the development of a prophylactic vaccine against the pandemic virus SARS-CoV-2. This research program aims to develop a prophylactic vaccine focused on memory T cells and based on a multiepitope- peptide approach (epitopes modified to induce strong and sustained CD8 immune responses).

The company is leveraging its expertise in the selection and optimization of disease-relevant peptides and using its established Memopi neo-epitope optimization technology to increase the memory immune response of T lymphocytes against specific antigens.

Using a bioinformatics approach and algorithms for predicting immunogenicity in the virus genome, OSE Immunotherapeutics’ R&D team has screened a large number of peptides derived from different proteins of SARS-CoV-2, SARS-CoV and MERS-CoV (coronavirus of the Middle East respiratory syndrome) and has selected the immuno-dominant epitopes from 8 major proteins of coronaviruses.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics